COSMOS Pharmaceutical (TSE:3349) Debt-to-Equity : 0.05 (As of Feb. 2024)

View and export this data going back to 2004. Start your Free Trial

What is COSMOS Pharmaceutical Debt-to-Equity?

COSMOS Pharmaceutical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was 円2,741 Mil. COSMOS Pharmaceutical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was 円7,962 Mil. COSMOS Pharmaceutical's Total Stockholders Equity for the quarter that ended in Feb. 2024 was 円224,280 Mil. COSMOS Pharmaceutical's debt to equity for the quarter that ended in Feb. 2024 was 0.05.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for COSMOS Pharmaceutical's Debt-to-Equity or its related term are showing as below:

TSE:3349' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.09 Max: 0.35
Current: 0.05

During the past 13 years, the highest Debt-to-Equity Ratio of COSMOS Pharmaceutical was 0.35. The lowest was 0.02. And the median was 0.09.

TSE:3349's Debt-to-Equity is ranked better than
86.31% of 548 companies
in the Healthcare Providers & Services industry
Industry Median: 0.46 vs TSE:3349: 0.05

COSMOS Pharmaceutical Debt-to-Equity Historical Data

The historical data trend for COSMOS Pharmaceutical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

COSMOS Pharmaceutical Debt-to-Equity Chart

COSMOS Pharmaceutical Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Debt-to-Equity

Get a 7-Day Free Trial

0.11

0.08

0.06

0.05

0.09

COSMOS Pharmaceutical Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Debt-to-Equity	Get a 7-Day Free Trial															0.03	0.09	0.06	0.05	0.05

Competitive Comparison of COSMOS Pharmaceutical's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

COSMOS Pharmaceutical's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where COSMOS Pharmaceutical's Debt-to-Equity falls into.

COSMOS Pharmaceutical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

COSMOS Pharmaceutical's Debt to Equity Ratio for the fiscal year that ended in May. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4485	+	13716)	/	211071
	=	0.09

COSMOS Pharmaceutical's Debt to Equity Ratio for the quarter that ended in Feb. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2741	+	7962)	/	224280
	=	0.05

COSMOS Pharmaceutical (TSE:3349) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

COSMOS Pharmaceutical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of COSMOS Pharmaceutical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

COSMOS Pharmaceutical (TSE:3349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » COSMOS Pharmaceutical Corp (TSE:3349) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, JPN, 812-0013

Website

http://www.cosmospc.co.jp

COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.

COSMOS Pharmaceutical (TSE:3349) Headlines

No Headlines